Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
Animals
Democratic Republic of the Congo
/ epidemiology
Disease Eradication
/ methods
Elephantiasis, Filarial
/ prevention & control
Endemic Diseases
/ prevention & control
Filaricides
/ administration & dosage
Humans
Mass Drug Administration
/ standards
Mozambique
/ epidemiology
Neglected Diseases
/ epidemiology
Outcome and Process Assessment, Health Care
Public Health
Quality Assurance, Health Care
Wuchereria bancrofti
/ drug effects
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
04
10
2018
accepted:
27
03
2019
revised:
17
07
2019
pubmed:
6
7
2019
medline:
7
1
2020
entrez:
6
7
2019
Statut:
epublish
Résumé
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transmission by administration of preventive mass drug administration (MDA) to the eligible population living in endemic districts. Suboptimal MDA coverage leads to persistent parasite transmission with consequential infection, disease and disability, and the need for continuing MDA rounds, requiring considerable investment. Routine coverage reports must be verified in each MDA implementation unit (IU) due to incorrect denominators and numerators used to calculate coverage estimates with administrative data. IU are usually the health districts. Coverage is verified so IU teams can evaluate their outreach and take appropriate action to improve performance. Mozambique and the Democratic Republic of Congo (DRC) have conducted MDA campaigns for LF since 2009 and 2014, respectively. To verify district reports and assess the declared achievement using administrative data of the minimum 80% coverage of eligible people (or 65% of the total population), both countries conducted rapid probability surveys using Lot Quality Assurance Sampling (LQAS)(n = 1102) in 2015 and 2016 in 58 IU in 49 districts. The surveys identified IU with suboptimal coverage, reasons residents did not take the medication, place where the medication was received, information sources, and knowledge about diseases prevented by the MDA. LQAS identified four inadequately covered IU triggering district team performance reviews with provincial and national teams and district retreatment. Provincial estimates using probability samples (weighted by populations sizes) were 10 and 17 percentage points lower than reported coverage in DRC and Mozambique. The surveys identified: absence from home during annual MDA rounds as the main reason for low performance and provided valuable information about pre-campaign and campaign activities resulting in improved strategies and continued progress towards elimination of LF and co-endemic Neglected Tropical Diseases.
Identifiants
pubmed: 31276494
doi: 10.1371/journal.pntd.0007337
pii: PNTD-D-18-01534
pmc: PMC6636779
doi:
Substances chimiques
Filaricides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0007337Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Trop Med Hyg. 2008 Apr;78(4):546-51
pubmed: 18385346
PLoS Negl Trop Dis. 2017 Apr 3;11(4):e0005476
pubmed: 28369129
Soc Sci Med. 2006 Sep;63(6):1648-60
pubmed: 16764978
Acta Trop. 2011 Sep;120 Suppl 1:S48-54
pubmed: 20932818
Clin Infect Dis. 2016 Feb 1;62(3):334-341
pubmed: 26486704
Am J Trop Med Hyg. 1998 Oct;59(4):606-14
pubmed: 9790439
Res Rep Trop Med. 2018 Mar 06;9:25-33
pubmed: 30050352
PLoS Negl Trop Dis. 2017 Jul 7;11(7):e0005576
pubmed: 28686693
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):589-91
pubmed: 11198635
BMC Public Health. 2005 Oct 11;5:108
pubmed: 16219104
Health Policy Plan. 2009 May;24(3):217-28
pubmed: 19304786
Infect Dis Poverty. 2015 Jul 30;4:34
pubmed: 26229599
Lancet Infect Dis. 2017 Apr;17(4):451-458
pubmed: 28012943
Int J Epidemiol. 1996 Feb;25(1):198-203
pubmed: 8666490
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13063-13068
pubmed: 30518561
Trop Med Int Health. 2006 Aug;11(8):1256-63
pubmed: 16903888
PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2447
pubmed: 24278486
Parasitol Today. 2000 Apr;16(4):135
pubmed: 10725894
Lancet. 2010 Oct 2;376(9747):1175-85
pubmed: 20739055